These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 15905990)

  • 21. The role of lymphadenectomy for testicular cancer: indications, controversies, and complications.
    Tarin T; Carver B; Sheinfeld J
    Urol Clin North Am; 2011 Nov; 38(4):439-49, vi. PubMed ID: 22045175
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Repeat retroperitoneal lymphadenectomy in advanced testicular cancer.
    Heidenreich A; Ohlmann C; Hegele A; Beyer J
    Eur Urol; 2005 Jan; 47(1):64-71. PubMed ID: 15582251
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Long-term clinical outcome after postchemotherapy retroperitoneal lymph node dissection in men with residual teratoma.
    Carver BS; Shayegan B; Serio A; Motzer RJ; Bosl GJ; Sheinfeld J
    J Clin Oncol; 2007 Mar; 25(9):1033-7. PubMed ID: 17261854
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Accuracy of clinical staging in non-seminomatous testicular cancer--a single centre experience of retroperitoneal lymph node dissection.
    Carlsson-Farrelly E; Boquist L; Ljungberg B
    Scand J Urol Nephrol; 1995 Dec; 29(4):501-6. PubMed ID: 8719370
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Risk factors for relapse in clinical stage I nonseminomatous testicular germ cell tumors: results of the German Testicular Cancer Study Group Trial.
    Albers P; Siener R; Kliesch S; Weissbach L; Krege S; Sparwasser C; Schulze H; Heidenreich A; de Riese W; Loy V; Bierhoff E; Wittekind C; Fimmers R; Hartmann M;
    J Clin Oncol; 2003 Apr; 21(8):1505-12. PubMed ID: 12697874
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Lymph node dissection in patients with renal cell carcinoma].
    Ebert T; Schnell D; Weissbach L
    Urologe A; 2005 Jun; 44(6):635-7. PubMed ID: 15871004
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Incidence, histology and management of intraluminal thrombus at post-chemotherapy retroperitoneal lymph node dissection.
    Johnston P; Beck SD; Cheng L; Masterson TA; Bihrle R; Kesler K; Foster RS
    J Urol; 2013 Sep; 190(3):874-7. PubMed ID: 23517745
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Value of sentinel node biopsy considering melanoma management as an example].
    Loquai C; Riemann H; Grabbe S
    Urologe A; 2005 Jun; 44(6):625-9. PubMed ID: 15891866
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Minimally Invasive Retroperitoneal Lymphadenectomy: Current Status.
    Kunit T; Janetschek G
    Urol Clin North Am; 2015 Aug; 42(3):321-9. PubMed ID: 26216819
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Laparoscopic retroperitoneal lymph-node dissection in the management of clinical stage I and II testicular cancer.
    Albqami N; Janetschek G
    J Endourol; 2005; 19(6):683-92; discussion 692. PubMed ID: 16053357
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Retroperitoneal laparoscopic lymph node dissection for staging non-seminomatous germ cell tumors before and after chemotherapy.
    Rassweiler JJ; Henkel TO; Stock C; Seemann O; Frede T; Alken P
    Lymphology; 1996 Mar; 29(1):36-44. PubMed ID: 8721978
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Management of patients with clinical stage I nonseminomatous testicular germ cell tumours: active surveillance versus primary chemotherapy versus nerve sparing retroperitoneal lymphadenectomy.
    Heidenreich A; Pfister D
    Arch Esp Urol; 2012 Mar; 65(2):215-26. PubMed ID: 22414450
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Contemporary management of postchemotherapy testis cancer.
    Daneshmand S; Albers P; Fosså SD; Heidenreich A; Kollmannsberger C; Krege S; Nichols C; Oldenburg J; Wood L
    Eur Urol; 2012 Nov; 62(5):867-76. PubMed ID: 22938868
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Low-volume nodal metastases detected at retroperitoneal lymphadenectomy for testicular cancer: pattern and prognostic factors for relapse.
    Rabbani F; Sheinfeld J; Farivar-Mohseni H; Leon A; Rentzepis MJ; Reuter VE; Herr HW; McCaffrey JA; Motzer RJ; Bajorin DF; Bosl GJ
    J Clin Oncol; 2001 Apr; 19(7):2020-5. PubMed ID: 11283135
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Results of bilateral nerve sparing laparoscopic retroperitoneal lymph node dissection for testicular cancer.
    Steiner H; Zangerl F; Stöhr B; Granig T; Ho H; Bartsch G; Peschel R
    J Urol; 2008 Oct; 180(4):1348-52; discussion 1352-3. PubMed ID: 18707723
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Retroperitoneal lymph node dissection in patients with low stage testicular cancer with embryonal carcinoma predominance and/or lymphovascular invasion.
    Stephenson AJ; Bosl GJ; Bajorin DF; Stasi J; Motzer RJ; Sheinfeld J
    J Urol; 2005 Aug; 174(2):557-60; discussion 560. PubMed ID: 16006891
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Nerve-sparing retroperitoneal lymph node dissection in patients with non-seminomatous testicular tumors at clinical stage 1].
    Ranieri A; Micheli E; Graziotti P; Tura M; Hurle RF; Romano C; Lembo A
    Arch Ital Urol Androl; 1994 Feb; 66(1):15-8. PubMed ID: 8012420
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Is modified retroperitoneal lymph node dissection alive for clinical stage I non-seminomatous germ cell testicular tumor?
    Basiri A; Ghaed MA; Simforoosh N; Tabibi A; Danesh A; Nouralizadeh A; Parizi MK
    Urol J; 2013; 10(2):873-7. PubMed ID: 23801470
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Randomized phase III trial comparing retroperitoneal lymph node dissection with one course of bleomycin and etoposide plus cisplatin chemotherapy in the adjuvant treatment of clinical stage I Nonseminomatous testicular germ cell tumors: AUO trial AH 01/94 by the German Testicular Cancer Study Group.
    Albers P; Siener R; Krege S; Schmelz HU; Dieckmann KP; Heidenreich A; Kwasny P; Pechoel M; Lehmann J; Kliesch S; Köhrmann KU; Fimmers R; Weissbach L; Loy V; Wittekind C; Hartmann M;
    J Clin Oncol; 2008 Jun; 26(18):2966-72. PubMed ID: 18458040
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Repeat retroperitoneal lymph-node dissection after chemotherapy for metastatic testicular germ cell tumour.
    Willis SF; Winkler M; Savage P; Seckl MJ; Christmas TJ
    BJU Int; 2007 Oct; 100(4):809-12. PubMed ID: 17711512
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.